ADM - Probiotic Blend - GRAS - Weight Management

Knowde Enhanced TDS

Identification & Functionality

Ingredient Name: Probiotic Blend
Food Ingredients Functions: Probiotic
Pharma & Nutraceuticals Functions: Probiotic
Technologies: Food Ingredients,
Pharmaceuticals & Nutraceuticals
Product Families: Pharmaceuticals & Nutraceuticals — Nutraceuticals & Supplements
Prebiotics, Probiotics & Postbiotics,
Supplements & Functional Ingredients
Food Ingredients — Nutrition & Fortification
Functional Ingredients,
Prebiotics, Probiotics & Postbiotics

Features & Benefits

Benefit Claims (Health): Promotes Healthy Gut Microflora,
Supports Healthy Aging,
Supports Skin Health
Labeling Claims: Generally Recognized As Safe (GRAS),
Gluten-free,
Halal,
Kosher,
Non-GMO,
Organic
Features: Supplementing your diet with the ADM Probiotic AD Blend may help support:

Overall skin health

Gut microbiome diversity

Clear & healthy skin

ADM Probiotic AD Blend is the choice ingredient to integrate into dietary supplements or nutritional products targeting skin health. It comes in a bulk powder format and is designed for dietary supplements, specialized in clinical nutrition, with excellent results in dairy and alternative dairy. It has a shelf life of 18 months.

Applications & Uses

Markets: Food & Nutrition
Applications: Food & Nutrition — Beverage
Other Non-Alcoholic Beverages
Food & Nutrition — Food
Dairy,
Dairy Substitutes
Food & Nutrition — Nutrition & Well Being
Clinical Nutrition,
Functional Foods,
Nutraceuticals & Supplements
Dosage Form: Capsules,
Stick,
Tablets
Food & Nutrition Applications: Clinical Nutrition,
Dairy Products,
Dietary Supplements,
Tablets

Properties

Regulatory & Compliance

Certifications & Compliance: Generally Recognized As Safe (GRAS),
Gluten-free,
Halal,
Kosher,
Organic Certified

Technical Details & Test Data

Test Data: Improvements In Scorad Index

After 12 weeks, 96% of participants in the ADM Probiotic AD Blend group showed an improvement in the SCORAD index (measured by the SCORAD* index), compared to 46% in the placebo group.

After 12 weeks of follow-up, the mean reduction in the SCORAD index in the probiotic group was 19.2 points greater than in the control group.

In relative terms, we observed a reduction in SCORAD of 83% in the probiotic group compared to a reduction of 24% in the placebo group (P < .001).

Investigator Global Assessment

Over the 12 week study period, 91% of individuals in the probiotic arm showed improvement to IGA score 0 or 1, compared to 21% in the placebo group.

In this trial, there was a significant reduction in the use of topical steroid in the probiotic group compared to the control group with an odds ratio (OR) of 0.63, indicating a relative risk reduction (RRR) of 37%.

Reduction in topical steroids use in this trial reached 45 days in the probiotic group compared to placebo.

Packaging & Availability

Storage & Handling